Article révisé par les pairs
Titre:
  • Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial
Auteur:Burris, Howard H.A.; Lebrun, Fabienne; Piccart-Gebhart, Martine; Rugo, Hope; Beck, Joseph Thaddeus; Neven, Patrick; Baselga, José; Petrakova, Katarina; Hortobagyi, Gabriel N.; Komorowski, Anna; Chouinard, Edmond; Young, Robyn; Gnant, Michael; Pritchard, Kathleen; Bennett, Lee; Ricci, Jean Francois; Bauly, Hounayda; Taran, Tetiana; Sahmoud, Tarek; Noguchi, Shinzaburo
Informations sur la publication:Cancer, 119, 10, page (1908-1915)
Statut de publication:Publié, 2013-05
Sujet CREF:Cancérologie
Mots-clés:advanced breast cancer
everolimus
exemestane
health-related quality of life
hormone receptor-positive
MeSH keywords:Adult
Aged
Androstadienes -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Aromatase Inhibitors -- administration & dosage
Breast Neoplasms -- drug therapy -- pathology -- psychology
Disease Progression
Double-Blind Method
Drug Administration Schedule
Female
Health Status
Humans
Middle Aged
Odds Ratio
Postmenopause
Proportional Hazards Models
Quality of Life
Questionnaires
Sirolimus -- administration & dosage -- analogs & derivatives
Treatment Outcome
Note générale:SCOPUS: ar.j
FLWIN
Langue:Anglais
Identificateurs:urn:issn:0008-543X
info:doi/10.1002/cncr.28010
info:scp/84877575581
info:pmid/23504821

Documents en relation

DI-fusion